Andrew D Ray (Andrew Ray)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Molecular pharmaceutics

Journal of the American Society for Mass Spectrometry

Rapid communications in mass spectrometry : RCM

The Analyst

AstraZeneca UK Ltd Macclesfield

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca UK Ltd Macclesfield Jul 04 2004

United Kingdom

Associate Principal Scientist

Publications

Mohammed Rahman, Bryan Marzullo, Stephen W Holman, Mark P Barrow, Andrew D Ray, Peter B O'Connor
Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry (2024)
Mohammed Rahman, Bryan Marzullo, Stephen W Holman, Mark P Barrow, Andrew D Ray, Peter B O'Connor
Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry 35 (2) (2024)
Mohammed Rahman, Bryan Marzullo, Stephen W Holman, Mark P Barrow, Andrew D Ray, Peter B O'Connor
Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry 35 (2) (2024)
Mohammed Rahman, Bryan Marzullo, Stephen W Holman, Mark P Barrow, Andrew D Ray, Peter B O'Connor
Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry 35 (2) (2024)
Mohammed Rahman, Bryan Marzullo, Stephen W Holman, Mark P Barrow, Andrew D Ray, Peter B O'Connor
Advancing PROTAC Characterization: Structural Insights through Adducts and Multimodal Tandem-MS Strategies. Journal of the American Society for Mass Spectrometry 35 (2) (2024)
Mohammed Rahman, Bryan P Marzullo, Yuko P Y Lam, Mark P Barrow, Stephen W Holman, Andrew D Ray, Peter B O'Connor
Unveiling the intricacy of gapmer oligonucleotides through advanced tandem mass spectrometry approaches and scan accumulation for 2DMS. The Analyst (2024)
Jayant Iyer, Michael Brunsteiner, Andrew D Ray, Adrian Davis, Isha Saraf, Amrit Paudel
Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State. Molecular pharmaceutics 20 (3) (2023)
Jayant Iyer, Michael Brunsteiner, Andrew D Ray, Adrian Davis, Isha Saraf, Amrit Paudel
Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State. Molecular pharmaceutics 20 (3) (2023)
Fabien Hannauer, Rachelle Black, Andrew D Ray, Eugen Stulz, G John Langley, Stephen W Holman
Review of fragmentation of synthetic single-stranded oligonucleotides by tandem mass spectrometry from 2014 to 2022. Rapid communications in mass spectrometry : RCM 37 (17) (2023)
Jayant Iyer, Michael Brunsteiner, Andrew D Ray, Adrian Davis, Isha Saraf, Amrit Paudel
Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State. Molecular pharmaceutics 20 (3) (2023)
Jayant Iyer, Michael Brunsteiner, Andrew D Ray, Adrian Davis, Isha Saraf, Amrit Paudel
Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State. Molecular pharmaceutics (2023)
Jayant Iyer, Michael Brunsteiner, Andrew D Ray, Adrian Davis, Isha Saraf, Amrit Paudel
Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State. Molecular pharmaceutics 20 (3) (2023)
Andrew D Ray, Graeme Clemens, Stephen W Holman
Application of open port sampling interface mass spectrometry (OPSI-MS) to deuterium exchange as an aid for structural elucidation. Rapid communications in mass spectrometry : RCM (2020)
Zoe Lewis, Bethany A Jackson, Alex Crampton, Andrew D Ray, Stephen W Holman
Towards a generic method for ion chromatography/mass spectrometry of low-molecular-weight amines in pharmaceutical drug discovery and development. Rapid communications in mass spectrometry : RCM (2020)

Andrew D Ray.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew Ray)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew D Ray (Andrew Ray)